Completed PHASE1 INTERVENTIONAL 2-arm NCT00535561

Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism

Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism: A Randomized, Double Blinded Study

Sponsor: Duzce University

Conditions Iron Deficiency Anemia Subclinical Hypothyroidism

Interventions Ferrous sulfate plus levothyroxine Ferrous sulfate tablets 325 mg, po, TID

Updated 6 times since 2017 Last updated: Feb 16, 2012 Started: Jun 30, 2007 Completion: Sep 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Iron Deficiency Anemia and Subclinical Hypothyroidism, this trial is completed. The trial is conducted by Duzce University and has accumulated 6 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jun 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Duzce University

Data source: Duzce University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Düzce, Turkey (Türkiye)